Abstract:Living donor liver transplantation (LDLT) provides a source for transplant in the setting of the deceased donor organ shortage. Seeing as living donors do not derive any medical benefit from the procedure, fully understanding the impact of donation on donor health-related quality of life (HRQOL) is essential. A systematic search of the MEDLINE database was performed from 2008-2020, using relevant Medical Subject Headings. Articles were evaluated for study design, cohort size and follow-up time and excluded if they contained significant methodological flaws. A total of 43 articles were included: 20 (47%) were cross-sectional and 23 (53%) were longitudinal. The mean number of donors per study was 142 (range:8-578) with follow-up ranging from 12-132 months. Forty-two unique HRQOL metrics were implemented across the 43 studies, the majority of which were questionnaires. Of the 31 studies that used the Medical Outcomes Study Short Form 36 questionnaire, 9.1% of donors reported physical QOL did not return to pre-LDLT levels for at least 2 years after donation. Mental QOL remained stable or improved after LDLT, with mean mental composite scores increasing from 50 to 52 at 3 months post-LDLT in one study. The predicted probability of poor sexual desire decreased at 1-year post-LDLT (male: 0.08, female: 0.26) relative to pre-LDLT (male: 0.44, female: 0.76; P<0.001) and three months post-LDLT (male: 0.35, female 0.69; P=0.001). Forty percent of donors found LDLT to be financially burdensome at 3 months and 19% at 2 years post-LDLT. Female gender and obesity were consistent predictors of worse HRQOL. Laparoscopy-assisted donor hepatectomy was associated with shorter hospitalizations than open donor hepatectomy (10.3 vs. 18.3 days, P=0.02). No studies used the National Institutes of Health Patient Reported Outcomes Measurement Information System (PROMIS) measures of HRQOL. Our review demonstrates that LDLT can have a long-lasting negative impact on physical QOL in 9.1% of donors and can cause both sexual dysfunction and significant financial strain. Future studies should consider using standardized and extensively validated patient reported outcomes measures, such as PROMIS, in order to directly compare outcomes across studies and gain further insight into the impact of LDLT on D-HRQOL.

Which recipient pretransplant factors, such as MELD, renal function, sarcopenia, and recent sepsis influence suitability for and outcome after living donor liver transplantation? A systematic review of the literature and expert panel recommendations

Short-term and long-term outcomes of liver transplantation using moderately and severely steatotic donor livers: A systematic review.

Predictors of Patient Survival Following Living Donor Liver Transplantation

Optimization of surgical evaluation algorithms for living donor liver transplantation

Survival after live donor versus deceased donor liver transplantation: propensity score-matched study

Living Donor Availability Improves Patient Survival in a North American Center

The aim of donor safety: surgical approaches and current results

Pre-operative assessment of living liver donors' liver anatomy and volumes

Benefit of living donor liver transplantation in graft survival for extremely high model for end-stage liver disease score ≥35

Evaluation outcomes of donors in living donor liver transplantation: a single-center analysis of 132 donors

In-Hospital Mortality After Adult Living Donor Liver Transplantation: Single-Center Experience

Donor quality of life after living donor liver transplantation: a review of the literature

Posttransplant Mortality Risk Assessment for Adult-to-adult Right-Lobe Living Donor Liver Recipients with Benign End-Stage Liver Disease

Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation.

Does Model for End-Stage Liver Disease Score Predict the Short-Term Outcome of Living Donor Liver Transplantation?

Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation

A Review of Life Quality in Living Donors after Liver Transplantation.

Pursuing living donor liver transplantation improves outcomes of patients with autoimmune liver diseases - An intention-to-treat analysis

Advances and innovations in living donor liver transplant techniques, matching and surgical training: Meeting report from the living donor liver transplant consensus conference

Liver Transplantation from Elderly Donors (≥85 Years Old)

The long-term follow-up of the living liver donors